The primary objective of the proposed phase II work is to expand the product offering and successfully commercialize the MVP that was successfully developed in phase I of this sbir contract. Phase…

Ended Definitive Contract Awarded Last action

Contract number
75N95020C00025
Awardee
Awarding agency
Obligated
$1,499,999

Award facts

Opportunity
  • PHS20191 Solicitation number
Contract value 100% obligated
$1,499,999.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 18 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
San Diego, CA 92130, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $1,499,999

About this award

S-3 Research LLC has been awarded a $1.5 million firm fixed price contract by the National Institutes of Health's National Institute on Drug Abuse to further develop and commercialize a minimum viable product originally created under Phase I of the Small Business Innovation Research program. Over the next two years, the company will focus on four technical objectives to expand its product offering and successfully bring the Phase I technology to market. The award is designated for total small business participation. As the lead agency for substance abuse and addiction research, the National Institute on Drug Abuse seeks to support innovative solutions through programs like SBIR that can help address public health challenges.

Description

The primary objective of the proposed phase II work is to expand the product offering and successfully commercialize the MVP that was successfully developed in phase I of this sbir contract. Phase II will focus on four specific overarching technical

Quick answers

Who was awarded contract 75N95020C00025?

75N95020C00025 was awarded to S-3 Research LLC by National Institute on Drug Abuse (National Institutes of Health) on September 18, 2020.

How much is contract 75N95020C00025 worth?

The government has obligated $1,499,999 on 75N95020C00025.

Was contract 75N95020C00025 competed?

The extent of competition for 75N95020C00025 was full and open competition after exclusion of sources. The government received 18 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award